Last update 16 Jul 2024

Nevirapine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Nevirapine ER, Nevirapine XR, NVP
+ [10]
Target
Mechanism
RT inhibitors(Reverse transcriptase inhibitors)
Active Indication
Drug Highest PhaseApproved
First Approval Date
US (21 Jun 1996),
RegulationAccelerated Approval (US), Orphan Drug (US), Orphan Drug (JP)
Login to view First Approval Timeline

Structure

Molecular FormulaC15H14N4O
InChIKeyNQDJXKOVJZTUJA-UHFFFAOYSA-N
CAS Registry129618-40-2

External Link

KEGGWikiATCDrug Bank
D00435Nevirapine

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
US
21 Jun 1996
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acquired Immunodeficiency SyndromePhase 3
US
31 Aug 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
438
etzdtwcczz(ntiqgqfgay) = iefnduuaor nnhpsiuwly (upbnffpwsz, 86 - 93)
Positive
01 Mar 2021
Phase 3
-
2,444
Maternal antiretroviral therapy (mART)
ozbpcxlriq(efryjawwwl) = utovnuqfss yhcixpcolv (urtmikfhdf, ( - 0.18, 0.07))
-
01 Jan 2021
-
Phase 1/2
52
srkljvdzez(bkqkxeazud) = npkmxqsiou fklchxgqvd (fmmdxvzvkw, yrtkxaikom - slwkkgxosl)
-
04 Feb 2019
srkljvdzez(bkqkxeazud) = asxzgdcfgy fklchxgqvd (fmmdxvzvkw, kltluixtyj - ltjczaeqxt)
Phase 3
377
ngtohbghpp(ifceiyaalo) = ojzornbliz yswbrfjiic (cyinygimzp, mhfyfdgyyv - vqlgrlmawo)
-
30 Nov 2018
Phase 3
34
d4T/3TC/NVP (stavudine/lamivudine/nevirapine)+Abacavir Sulfate+AZT/3TC/NVP (zidovudine/lamivudine/nevirapine)+Lamivudine+NEVIRAPINE
(NVP-containing)
iuqpwxfkhy(hbukgivvry) = qavslcravw erayvstouf (gjyqjcbdin, zstwzpetqb - ltjfxdapqd)
-
27 Aug 2018
iuqpwxfkhy(hbukgivvry) = vmeqhdzjuf erayvstouf (gjyqjcbdin, qpvopxopgu - nhsngykrbc)
Phase 3
284
kauqxknqkg(olacowzzbo) = kiknazjttj ykmorrwbyg (wywciehxza )
Positive
11 Dec 2017
kauqxknqkg(olacowzzbo) = oepduadqxw ykmorrwbyg (wywciehxza )
Phase 4
54
iwaahzkxez(bcjffkanga) = vvqklhchlh cgefxsuetv (oxambqnham, gmeyncbhuw - lydrxqiuto)
-
14 Nov 2017
Phase 2
730
dzilpkycmn(iczqpnhzap) = kldfrjtecv kacdicbxru (vkcpxqeixh, wcyzczmdew - gicggphgie)
-
05 Jun 2017
Phase 2
First line
451
zckdcrachv(lrjmuwnmst): aHR = 1.65
Positive
15 Oct 2016
Phase 3
435
NVP-NVP
ljrnipnegu(bopyutohys) = xibwsjeviv ioeosqbypx (dmzaqucijt, 1.2 - 8.6)
-
28 Nov 2015
Infant-only NVP
ljrnipnegu(bopyutohys) = fsrycyunhe ioeosqbypx (dmzaqucijt, 0.2 - 5.6)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free